(Q35089523)

6 August 2017

0 references

Thrombophilic disorders and fetal loss: a meta-analysis (English)

1 reference

6 August 2017

0 references

1 reference

4

Ian Shrier

1 reference

6 August 2017

Evelyne Rey

1

1 reference

6 August 2017

Susan R Kahn

series ordinal

2

1 reference

6 August 2017

Michèle David

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

361

1 reference

6 August 2017

issue

9361

1 reference

6 August 2017

page(s)

901-908

1 reference

Genetic susceptibility to venous thrombosis

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Increased frequency of genetic thrombophilia in women with complications of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

First-trimester repeated abortion is not associated with activated protein C resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Increased resistance to activated protein C and factor V Leiden in recurrent abortions. Review of other hypercoagulability factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

G20210A prothrombin gene mutation: prevalence in a recurrent miscarriage population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Factor V Leiden mutation as a risk factor for recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Primary habitual abortions are associated with high frequency of factor V Leiden mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Factor V Leiden as a risk factor for miscarriage and reduced fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Mutations in coagulation factors in women with unexplained late fetal loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Increased fetal loss in women with heritable thrombophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Pregnancy loss and thrombosis with protein C deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912771-7

7 January 2021

10.1016/S0140-6736(03)12771-7

Identifiers

DOI

1 reference

6 August 2017

1 reference